What was the market valuation of the interventional radiology-products market in 2024?

The market valuation was $1420.0 Million in 2024. Read More

What is the projected market valuation for the interventional radiology-products market by 2035?

The projected valuation for 2035 is $2640.0 Million. Read More

What is the expected CAGR for the interventional radiology-products market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period is 5.8%. Read More

Which product type had the highest valuation in the interventional radiology-products market?

Radiology Visualization Systems had the highest valuation, ranging from $350.0 Million to $700.0 Million. Read More

What are the key players in the interventional radiology-products market?

Key players include Medtronic, Boston Scientific, Siemens Healthineers, Johnson & Johnson, Bayer AG, Abbott Laboratories, Terumo Corporation, Cook Medical, and Philips Healthcare. Read More

Which application segment is projected to have the highest valuation in the interventional radiology-products market?

The Urology application segment is projected to have the highest valuation, ranging from $400.0 Million to $800.0 Million. Read More

What is the valuation range for Ablation Devices in the interventional radiology-products market?

The valuation range for Ablation Devices is between $320.0 Million and $540.0 Million. Read More

Which end user segment is expected to dominate the interventional radiology-products market?

Hospitals are expected to dominate the market, with a valuation range of $850.0 Million to $1600.0 Million. Read More

What is the valuation range for Guide Wires in the interventional radiology-products market?

The valuation range for Guide Wires is between $250.0 Million and $450.0 Million. Read More

Which procedure type is anticipated to show significant growth in the interventional radiology-products market?

Ablation procedures are anticipated to show significant growth, with a valuation range of $370.0 Million to $640.0 Million. Read More

GCC Interventional Radiology Products Market

ID: MRFR/HC/50181-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

GCC Interventional Radiology Products Market Research Report By Product Type (Catheters, Guide Wires, Embolic Agents, Radiology Visualization Systems, Ablation Devices), By Procedure Type (Angiography, Biliary Interventions, Biopsy, Drainage Procedures, Ablation), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers) and By Application (Oncology, Cardiology, Urology, Neurology) -Forecast to 2035

GCC Interventional Radiology Products Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product Type (USD Million)
  1. 4.1.1 Catheters
  2. 4.1.2 Guide Wires
  3. 4.1.3 Embolic Agents
  4. 4.1.4 Radiology Visualization Systems
  5. 4.1.5 Ablation Devices
2. 4.2 Healthcare, BY Procedure Type (USD Million)
  1. 4.2.1 Angiography
  2. 4.2.2 Biliary Interventions
  3. 4.2.3 Biopsy
  4. 4.2.4 Drainage Procedures
  5. 4.2.5 Ablation
3. 4.3 Healthcare, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Ambulatory Surgical Centers
  3. 4.3.3 Diagnostic Imaging Centers
4. 4.4 Healthcare, BY Application (USD Million)
  1. 4.4.1 Oncology
  2. 4.4.2 Cardiology
  3. 4.4.3 Urology
  4. 4.4.4 Neurology
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bayer AG (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Abbott Laboratories (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Terumo Corporation (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cook Medical (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Philips Healthcare (NL)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 GCC MARKET ANALYSIS BY PROCEDURE TYPE
4. 6.4 GCC MARKET ANALYSIS BY END USER
5. 6.5 GCC MARKET ANALYSIS BY APPLICATION
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY END USER, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY PROCEDURE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Healthcare Market Segmentation

Healthcare By Product Type (USD Million, 2025-2035)

Catheters
Guide Wires
Embolic Agents
Radiology Visualization Systems
Ablation Devices

Healthcare By Procedure Type (USD Million, 2025-2035)

Angiography
Biliary Interventions
Biopsy
Drainage Procedures
Ablation

Healthcare By End User (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Diagnostic Imaging Centers

Healthcare By Application (USD Million, 2025-2035)

Oncology
Cardiology
Urology
Neurology

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”